Karen Sterling
Stock Analyst at Westpark Capital
(0.43)
# 4,042
Out of 4,382 analysts
4
Total ratings
33.3%
Success rate
-39.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Karen Sterling
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TTRX Turn Therapeutics | Initiated Coverage: Buy | $6.15 | $5.28 | +16.48% | 1 | Jan 12, 2026 | |
| REGN Regeneron Pharmaceuticals | Initiated Coverage: Hold | n/a | $635.45 | n/a | 1 | Sep 15, 2023 | |
| NRXS NeurAxis | Initiated Coverage: Buy | $7.5 | $6.84 | n/a | 1 | Aug 23, 2023 | |
| VRTX Vertex Pharmaceuticals | Initiated Coverage: Hold | n/a | $446.83 | n/a | 1 | May 25, 2023 |
Turn Therapeutics
Jan 12, 2026
Initiated Coverage: Buy
Price Target: $6.15
Current: $5.28
Upside: +16.48%
Regeneron Pharmaceuticals
Sep 15, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $635.45
Upside: n/a
NeurAxis
Aug 23, 2023
Initiated Coverage: Buy
Price Target: $7.5
Current: $6.84
Upside: n/a
Vertex Pharmaceuticals
May 25, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $446.83
Upside: n/a